AstraZeneca
AZN
#63
Rank
NZ$448.15 B
Marketcap
NZ$288.97
Share price
-0.23%
Change (1 day)
22.20%
Change (1 year)

EPS for AstraZeneca (AZN)

EPS in 2026 (TTM): NZ$11.96

According to AstraZeneca's latest financial reports the company's current EPS (TTM) is NZ$11.89. In 2024 the company made an earnings per share (EPS) of NZ$7.77 an increase over its 2023 EPS that were of NZ$6.57.

EPS history for AstraZeneca from 2011 to 2026

Annual EPS

Year EPS Change
2026 (TTM)NZ$11.96
2024NZ$7.7718.23%
2023NZ$6.5781.13%
2022NZ$3.63631.03%
2021NZ$0.50-88.11%
2020NZ$4.17136.89%
2019NZ$1.76-39.41%
2018NZ$2.91-28.27%
2017NZ$4.05-14.37%
2016NZ$4.7424.11%
2015NZ$3.82127.55%
2014NZ$1.68-51.96%
2013NZ$3.49-58.95%
2012NZ$8.50-32.2%
2011NZ$12.54

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
NZ$14.95 25.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
NZ$12.01 1.01%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
NZ$2.24-81.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
NZ$6.17-48.08%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
NZ$48.29 306.12%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
NZ$4.38-63.17%๐Ÿ‡ซ๐Ÿ‡ท France
Biogen
BIIB
NZ$16.00 34.53%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$6.09-48.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
NZ$6.09-48.78%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
NZ$6.65-44.08%๐Ÿ‡ฌ๐Ÿ‡ง UK